AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NUHEARA LIMITED

0.081

0.000

Volume:- -

Turnover:- -

Market Cap:21.95M

PE:-1.11

High:0.081

Open:0.081

Low:0.081

Close:0.081

52wk High:0.081

52wk Low:0.081

Shares:271.00M

Float Shares:172.70M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.073

EPS(LYR):-0.084

ROE:-347.83%

ROA:-58.00%

PB:4.30

PE(LYR):-0.97

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research

NUH And NUS Launch New Molecular Imaging And Theranostic Centre To Strengthen Patient Care And Research

Siemens Healthineers and National University Hospital Partner on Research to Advance Non-Invasive Liver Disease Diagnostics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NUH.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NUH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NUH.AU\",,,,,undefined,":{"symbol":"NUH.AU","market":"AU","secType":"STK","nameCN":"NUHEARA LIMITED","latestPrice":0.081,"timestamp":1770354000000,"preClose":0.081,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"NUHEARA LIMITED","floatShares":172697276,"shares":271000000,"eps":-0.073,"marketStatus":"Market Closed","change":0,"latestTime":"02-06 16:00:00 AEDT","open":0.081,"high":0.081,"low":0.081,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.073,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.081,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NUH.AU\",,,,,undefined,":{"symbol":"NUH.AU","floatShares":172697276,"roa":"-58.00%","roe":"-347.83%","lyrEps":-0.083876,"shares":271000000,"dividePrice":0,"high":0.081,"amplitude":0,"preClose":0.081,"low":0.081,"week52Low":0.081,"pbRate":"4.30","psRate":"11.37","week52High":0.081,"institutionHeld":0,"latestPrice":0.081,"eps":-0.073,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.073,"open":0.081,"prevYearClose":0.081,"prevWeekClose":0.081,"prevMonthClose":0.081,"prevQuarterClose":0.081,"fiveDayClose":0.081,"twentyDayClose":0.081,"sixtyDayClose":0.081},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NUH.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2025-03-03","symbol":"NUH.AU","reason":null,"defaultRemindTime":1740956400000,"announcedDate":"2025-03-03","type":"delisting","dateTimestamp":1740920400000},{"date":"2023-04-28","symbol":"NUH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1682640000000,"name":null,"time":"","dateTimestamp":1682604000000,"actualEps":null},{"date":"2022-10-31","symbol":"NUH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1667170800000,"name":null,"time":"","dateTimestamp":1667134800000,"actualEps":null},{"market":"AU","date":"2022-05-04","symbol":"NUH.AU","defaultRemindTime":1651622400000,"type":"split","dateTimestamp":1651586400000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NUH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NUH.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583534689","title":"Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2583534689","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583534689?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:05","pubTimestamp":1763006700,"startTime":"0","endTime":"0","summary":"Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE, Nov. 13, 2025 /PRNewswire/ --Agilent Technologies Inc. announced the signing of a five-year Memorandum of Understanding  with National Heart Centre Singapore  to accelerate innovation in metabolic heart failure research, one of the most complex and underserved areas in cardiovascular medicine.Agilent Seahorse XF Flex Analyzer 3D Workflow Features Metabolic Profile that Serves as Dynamic Biomarkers of Cell Health. NHCS has established itself as a leader in modelling monogenic cardiac diseases using patient-specific induced pluripotent stem cells , which led to novel therapeutic targets now undergoing clinical evaluation,. Building on this foundation, the integration of Agilent's next-generation technology and NHCS's Preclinical Platform for Development of Therapeutics for Heart Failure  positions the collaborati","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2822042/Signing_Ceremony_NHCS_and_Agilent_13Nov2025.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2822042/Signing_Ceremony_NHCS_and_Agilent_13Nov2025.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/agilent-and-national-heart-centre-singapore-sign-agreement-to-advance-metabolic-heart-failure-research-302613983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4585","LU1543694498.USD","LU2092937221.SGD","BK4121","NUS","NUH.AU","LU2041044095.USD","BK7098","IE00BN0W2T93.GBP","BK4532","BK4567","A","LU2089279066.USD","IE00BN0W2V16.EUR","BK4588","NUS.AU","NHLD","LU0347712357.USD","IE00BN0W2W23.USD","LU2413666426.HKD","LU1721428933.USD","LU2229751404.USD","LU2413666699.HKD","LU1165135440.EUR"],"gpt_icon":0},{"id":"2575714493","title":"NUH And NUS Launch New Molecular Imaging And Theranostic Centre To Strengthen Patient Care And Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2575714493","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575714493?lang=en_us&edition=fundamental","pubTime":"2025-10-16 17:55","pubTimestamp":1760608500,"startTime":"0","endTime":"0","summary":"Powered by Singapore's first next-generation total-body PET/CT system, the new facility aims to transform diagnostics, treatment and research in cancer and beyond. SINGAPORE, Oct. 16, 2025 /PRNewswire/ -- The National University Hospital  and the National University of Singapore  Clinical Imaging Research Centre  have jointly launched the Molecular Imaging and Theranostic Centre, a novel integrated clinical, education, research & development facility that brings together advanced diagnostics, targeted therapy and pioneering research. This landmark development is set to transform the way diseases such as cancer are diagnosed, treated and studied, positioning Singapore at the forefront of molecular imaging in Asia.","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2798034/DSF1982_1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2798034/DSF1982_1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/nuh-and-nus-launch-new-molecular-imaging-and-theranostic-centre-to-strengthen-patient-care-and-research-302586183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NUS.AU","NUH.AU","BK4532","BK4183","BK7098","NUS","CIRC","BK4585"],"gpt_icon":0},{"id":"2573916985","title":"Siemens Healthineers and National University Hospital Partner on Research to Advance Non-Invasive Liver Disease Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2573916985","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573916985?lang=en_us&edition=fundamental","pubTime":"2025-10-08 11:15","pubTimestamp":1759893300,"startTime":"0","endTime":"0","summary":"Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease. Advancing ultrasound technologies that are safer, more accessible alternatives to invasive diagnostic procedures. Research led by globally respected hepatologist Associate Professor Dan Yock Young. MASLD, formerly known as Non-Alcoholic Fatty Liver Disease , is now the most common cause of chronic liver disease worldwide. The elevated burden in Singapore reflects rising levels of obesity, sedentary lifestyles, and associated metabolic conditions – a serious trend that demands a more efficient, patient-friendly approach to liver care.The research initiative will be led by Associate Professor Dan Yock Young, Senior Consultant, Division of Gastroenterology and Hepatology, Department of Medicine at NUH, and Associate Professor, Department of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore. A globa","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2791291/image_5033471_4684377.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2791291/image_5033471_4684377.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/siemens-healthineers-and-national-university-hospital-partner-on-research-to-advance-non-invasive-liver-disease-diagnostics-302577831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NHLD","BK7098","NUH.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NUH.AU\",params:#limit:6,delay:true,,,undefined,":[]}}